Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI)
Jordan
· Delayed Price · Currency is JOD
1.250
0.00 (0.00%)
At close: Dec 1, 2024
DADI Company Description
Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, produces, markets, and commercializes medicines and wellness consumer products.
The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, nervous system, gastrointestinal, dermatology, eye-ear preparations, genitourinary system and sex hormones, analgesic, respiratory system, and vitamins and natural products.
It serves patients in approximately 40 countries throughout the Middle East, North Africa, and Europe.
The company was incorporated in 1975 and is headquartered in Amman, Jordan.
Dar Al Dawa Development and Investment Co. Ltd.
Country | Jordan |
Founded | 1975 |
Industry | Pharmaceutical Preparations |
Employees | 1,067 |
CEO | Khaled Harb |
Contact Details
Address: PO Box 9364 Amman, 11191 Jordan | |
Phone | 9626 5539416 |
Website | dadgroup.com |
Stock Details
Ticker Symbol | DADI |
Exchange | Amman Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | JOD |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Khaled Harb | Chief Executive Officer |
Shadi Saqfelhait | Chief Financial Officer |
Mohammed Alsous | Chief Operating Officer |